Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
- LOS ANGELES (AP) — Shohei Ohtani’s first walk-off hit for the Los Angeles Dodgers was also his first2024-05-21
1st Chinese tour group lands in New Zealand in 3 years
Chinese tourists take part in a welcome ceremony at the Auckland Airport in Auckland, New Zealand, M2024-05-21BRICS summit expected to promote S. Africa's tourism sector
The Tourism Business Council of South Africa (TBCSA) expects that the upcoming BRICS summit can boos2024-05-21China's benchmark interbank gold prices mixed Monday
BEIJING, May 6 (Xinhua) -- China's benchmark prices for spot interbank gold transactions were mixed2024-05-21Kosovo prepares a new draft law on renting prison cells to Denmark after the first proposal failed
PRISTINA, Kosovo (AP) — Kosovo’s Cabinet renewed efforts with a new draft law on renting a prison in2024-05-21Tourism festival spurs consumption in Shanghai
Cultural and tourism consumption boomed during the three-week Shanghai Tourism Festival, with the ci2024-05-21
atest comment